Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Translational Development Acquisition (TDAC) Return on Equity (2024 - 2026)

Translational Development Acquisition's Return on Equity history spans 3 years, with the latest figure at 0.01% for Q1 2026.

  • On a quarterly basis, Return on Equity fell 1.0% to 0.01% in Q1 2026 year-over-year; TTM through Mar 2026 was 0.01%, a 1.0% decrease, with the full-year FY2025 number at 0.01%, down 1.0% from a year prior.
  • Return on Equity came in at 0.01% for Q1 2026, up from 0.01% in the prior quarter.
  • The five-year high for Return on Equity was 0.0% in Q4 2024, with the low at 0.01% in Q4 2025.
  • Historically, Return on Equity has averaged 0.01% across 3 years, with a median of 0.01% in 2025.
  • Peak annual rise in Return on Equity hit -1bps in 2025, while the deepest fall reached -1bps in 2025.
  • Year by year, Return on Equity stood at 0.0% in 2024, then plummeted by -4293bps to 0.01% in 2025, then rose by 6bps to 0.01% in 2026.
  • Business Quant data shows Return on Equity for TDAC at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.